Skip to main content
Article thumbnail
Location of Repository

Deletion of the MBII-85 snoRNA Gene Cluster in Mice Results in Postnatal Growth Retardation

By Boris V Skryabin, Leonid V Gubar, Birte Seeger, Jana Pfeiffer, Sergej Handel, Thomas Robeck, Elena Karpova, Timofey S Rozhdestvensky and Jürgen Brosius

Abstract

Prader-Willi syndrome (PWS [MIM 176270]) is a neurogenetic disorder characterized by decreased fetal activity, muscular hypotonia, failure to thrive, short stature, obesity, mental retardation, and hypogonadotropic hypogonadism. It is caused by the loss of function of one or more imprinted, paternally expressed genes on the proximal long arm of chromosome 15. Several potential PWS mouse models involving the orthologous region on chromosome 7C exist. Based on the analysis of deletions in the mouse and gene expression in PWS patients with chromosomal translocations, a critical region (PWScr) for neonatal lethality, failure to thrive, and growth retardation was narrowed to the locus containing a cluster of neuronally expressed MBII-85 small nucleolar RNA (snoRNA) genes. Here, we report the deletion of PWScr. Mice carrying the maternally inherited allele (PWScrm−/p+) are indistinguishable from wild-type littermates. All those with the paternally inherited allele (PWScrm+/p−) consistently display postnatal growth retardation, with about 15% postnatal lethality in C57BL/6, but not FVB/N crosses. This is the first example in a multicellular organism of genetic deletion of a C/D box snoRNA gene resulting in a pronounced phenotype

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2323313
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). Razin A
    2. (2001). Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.
    3. (1990). Prevalence study of Prader-Willi syndrome in North Dakota.
    4. (2001). Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region.
    5. (2005). Prader-Willi syndrome.
    6. (2004). Prader-Willi syndrome: advances in genetics, pathophysiology and treatment.
    7. (2001). The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.
    8. (2004). Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn.
    9. (2005). Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region.
    10. (1992). A candidate mouse model for Prader-Willi syndrome which shows an absence of Snrpn expression.
    11. (1997). A candidate model for Angelman syndrome in the mouse.
    12. (1999). A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and Angelman syndromes.
    13. (1998). A mouse model for Prader-Willi syndrome imprinting-centre mutations.
    14. (1999). Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome.
    15. (1999). Incriminating gene suspects, Prader-Willi style.
    16. (2005). Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in PraderWilli syndrome mouse models.
    17. (2001). The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/ Angelman domain in mice.
    18. (2005). Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in PraderWilli syndrome.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.